California lawmakers are advancing a bill that would require governors to deny extradition requests for healthcare providers who prescribe abortion medication or administer gender-affirming care. The legislation, authored by state Assembly member Rebecca Bauer-Kahan, is currently being heard in committee and would also shield anyone in California who helps patients travel to California or another state to receive legal reproductive or gender-affirming care.

In January, Louisiana sought to extradite California physician Remy Coeytaux, who was accused of mailing abortion pills to a patient in that state. California Gov. Gavin Newsom refused the extradition request. Newsom’s action aligns with his public stance that California would “not ever” allow “extremist politicians” to punish its doctors, though his spokesperson Marissa Saldivar said the governor does not comment on pending legislation. New York Gov. Kathy Hochul similarly denied Louisiana’s February 2025 extradition request for a doctor in her state.

The proposed bill seeks to codify such refusals into law. Currently, California’s protections for abortion providers stem from an executive order, a mechanism shared by Arizona, Michigan, North Carolina, and Pennsylvania, according to the Guttmacher Institute. Amanda Barrow, a senior staff attorney at the Center on Reproductive Health, Law, and Policy at UCLA Law, said passing extradition protections into statute would put California on firmer footing because an executive order “could be revoked by a governor who is anti-abortion or anti-gender-affirming-care.”

Republican gubernatorial candidate Steve Hilton has said he would honor extradition requests from other states for physicians accused of prescribing abortion medication if elected. Hilton, a former Fox News host endorsed by President Donald Trump, has also vowed to revoke California’s executive order protecting abortion providers. He stated that Louisiana “is trying to uphold what its people voted for, and California is undermining it,” and told KQED in January, “Just as I wouldn’t want to see Louisiana coming in and undermining something that we voted for here in California.”

In contrast, Democratic candidate Xavier Becerra, who leads Hilton 52% to 31% in May polling by the University of California-Berkeley Institute of Government Studies, has said he would deny extradition requests for physicians accused of prescribing abortion medication. During a May gubernatorial debate, Becerra said he was strident about protecting reproductive rights as the state’s attorney general. Asked directly about allowing California physicians to be extradited, he replied, “Absolutely no.”

Supporters of the bill argue that legal protections should not hinge on the political preferences of a single governor. Alyssa Sherer, a nurse practitioner and medical director at Hey Jane, a telehealth medication abortion provider, spoke in favor of the bill at a Senate committee hearing in June. “Protecting providers from prosecution should not rely on shifting political winds or a single person’s decision,” Sherer said. The California chapter of the American College of Emergency Physicians is also backing the legislation. Kamara Graham, a Sacramento emergency room doctor and vice president of the chapter, described the personal stakes for providers: “It’s really conflicting and hard for us to weigh that concern of: Will I get extradited and charged and potentially be taken away from my family? Or do I do the right thing for my patient?”

Opponents warn the bill could undermine interstate legal cooperation. Greg Burt, vice president of the California Family Council, has spoken against shield laws at the State Capitol. “If California says, ‘We’re not going to honor any other state’s laws. We’re going to ship abortion pills into your states. You can’t have a law that says abortion is illegal,’ I don’t know — that doesn’t seem like a workable situation,” Burt said.

The debate occurs against a backdrop of sharply divided state abortion policies. Since the U.S. Supreme Court overturned Roe v. Wade in 2022, ending federal legal protections for abortion, thirteen states have banned abortion outright, and twenty-eight others ban it between six weeks and viability. In response, twenty-one states and Washington, D.C., have enacted shield laws similar to California’s. Hawai‘i this year added gender-affirming care to its existing protections, while Oregon expanded its extradition safeguards to prohibit law enforcement from cooperating with out-of-state or federal investigations into care legal within Oregon.

Meanwhile, states with abortion bans have tightened penalties. The governors of Mississippi, Oklahoma, and South Dakota signed bills this year criminalizing the sale, purchase, or distribution of abortion-inducing medication. Those laws make providing such drugs a felony punishable by up to 10 years in prison and tens of thousands of dollars in fines. Mississippi also amended its controlled substances code to classify abortion pills as a criminal category.

The legal and regulatory landscape remains fluid. The Food and Drug Administration confirmed it is conducting a safety review of mifepristone, one of two medications used in most U.S. abortions, though it maintains the drug is safe and effective. If the FDA were to reverse its position and declare mifepristone unsafe, such a ruling would supersede state laws, even in states where abortion remains legal. In anticipation, many telehealth groups have said they would switch to using only misoprostol if mifepristone is restricted. Texas Attorney General Ken Paxton, a Republican running for the U.S. Senate, previously obtained a default judgment of more than $100,000 against the New York doctor targeted by Louisiana, but a judge dismissed the judgment, citing New York’s shield law.

Why It Matters

The bill represents a significant escalation in California’s efforts to insulate healthcare providers from legal actions by states with restrictive abortion laws. With reproductive rights increasingly contested across state lines, codifying non-extradition protections would make California’s stance less vulnerable to changes in executive leadership. The measure also reflects a broader national trend: as more states enact criminal penalties for abortion-related care, sanctuary states are strengthening legal shields to protect both providers and patients crossing state borders for services that remain legal in their destination.

The outcome could influence similar legislative efforts nationwide and shape the legal risks faced by healthcare workers in an era of fragmented state abortion policies. Given that telehealth abortions in states with total bans rose from 74,000 in 2024 to 92,000 in 2025, according to the Guttmacher Institute, the practical impact of such protections is growing. How California balances its commitment to reproductive autonomy with interstate legal obligations may set a precedent for other states navigating the same tensions.